Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

LexaGene to expand its brand awareness at three investor relations conferences in October

Massachusetts-based LexaGene is marketing a point-of-need in-clinic PCR system that turns results around in about two hours known as the MiQLab

LexaGene Holdings Inc. (TSX-V:LXG, OTCQB:LXXGF) has announced that it will be featured at three investor relations conferences in early October.

The company’s management will also participate in one-on-one meetings at each conference.

Beverly, Massachusetts-based LexaGene is marketing a point-of-need in-clinic PCR system that turns results around in about two hours known as the MiQLab.

READ: LexaGene successfully demonstrates its MiQLab diagnostic tool for the first time at series of trade shows

“Attending these conferences allows us to update current investors and introduce LexaGene as an investment opportunity to future investors,” said Dr. Jack Regan, LexaGene’s CEO and founder, in a statement.

“The veterinary trade shows we attended in September made it clear that our technology is at the forefront of innovation and is expected to change the way diagnostics are performed in veterinary medicine. We are excited about the increasing adoption of our MiQLab system into more veterinary hospitals, where veterinarians are interested in providing the best possible care by utilizing the MiQLab for rapid in-clinic PCR testing for pathogens and antimicrobial resistance.”

The three conferences include:

  • BioFuture 2021, October 5-6: Top innovators, investors, and business leaders will come together to participate in discussions that will shape and transform the future of healthcare by harnessing the power of the life sciences ecosystem and its impact on healthcare, LexaGene will provide insights into its open-access technology and the role it can play in key life science verticals.
  • Lytham Partners Fall 2021 Investor Conference, October 5-7. The next generation of innovators will offer a diverse and effective platform for connecting small-cap companies with high-quality and focused institutional investors. An audio webcast of the presentation will be made available on LexaGene’s website.
  • Small Cap Growth Virtual Investor Conference, October 7. It will be a live, interactive event, where investors are invited to ask companies questions in real-time. It is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to meet and present directly with investors.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK